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King Sau
osting by EAbstract A simple, precise, and accurate method is developed and validated for the analysis of
pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and
paracetamol in tablet formulations. The method has shown adequate separation of the four ingre-
dients from each other. Separation was achieved on a silica column (5 lm, 125 · 4.6 mm inner
diameter) using a mobile phase consisting of methanol/ammonium dihydrogen phosphate buffer
(90:10, v/v) at a ﬂow rate of 1.0 ml/min and UV detection at 220 nm. This new method is validated
in accordance with USP requirements for new methods for assay determination, which include
accuracy, precision, selectivity, linearity and range, robustness and ruggedness. The current method
demonstrates good linearity over the range of 0.15–0.45 mg/ml of pseudophedrine hydrochloride
with r2 of 0.996, and in the range of 0.075–0.225 mg/ml of dextromethorphan hydrobromide with
r2 of 0.992, and in the range of 0.01–0.03 mg/ml of chlorpheniramine maleate with r2 of 0.994, and
in the range of 0.25–0.75 mg/ml of paracetamol with r2 of 0.991. The average recovery of the
method is 99.7%, 98.6%, 98.1%, and 99.2% for pseudophedrine hydrochloride, dextromethorphan
hydrobromide, chlorpheniramine maleate, and paracetamol, respectively. The degree of reproduc-
ibility of the results obtained as a result of small deliberate variations in the method parameters and
by changing analytical operator has proven that the method is robust and rugged.
ª 2010 King Saud University. All rights reserved.ity. All rights reserved. Peer-
d University.
lsevier1. Introduction
A combination of pseudophedrine hydrochloride, dextrometh-
orphan hydrobromide, chlorpheniramine maleate, and paracet-
amol is used in pharmaceutical preparations for reducing
symptoms which are usually associated with the common cold.
Paracetamol has analgesic and antipyretic effects, pseudophe-
drine acts a decongestant, dextromethorphan is used as an
104 F. Al-Rimawiantitussive agent, and chlorpheniramine is used as an anti-
histamine. Chemical structures of these four compounds are
shown in Fig. 1. In this respect, an analytical method is needed
for the determination of this combination. In the USP (United
States Pharmacopeia 32, 2009), there are two methods for
determination of this combination; one is for the analysis of
pseudophedrine hydrochloride, dextromethorphan hydrobro-
mide, chlorpheniramine maleate, and another for analysis of
paracetamol. In the method for pseudophedrine hydrochloride,
dextromethorphan hydrobromide, chlorpheniramine maleate,
an ion-pairing reagent (sodium lauryl sulfate) is employed,
and evidences shows that the use of ion pairing agent alters
the chemistry of the column, rendering it useless for separation
except for ion-pair analysis (Milenkova et al., 2003). Also, the
method for pseudophedrine hydrochloride, dextromethorphan
hydrobromide, chlorpheniramine maleate is not simultaneous
i.e. for each analyte, different standard and sample prepara-
tions are needed. Many analytical methods are also described
in the scientiﬁc literature for analysis of this combination. In
1984, Das Gupta and Heble (1984) have developed an HPLC
method for the quantitation of paracetamol, chlorpheniramine
maleate, dextromethorphan hydrobromide, and phenylpropa-
nolamine hydrochloride in different pharmaceutical dosage
forms using a single column and three different mobile phases
(Das Gupta and Heble, 1984). In 1987, Biemer has described
a simultaneous analysis of paracetamol, pseudophedrine
hydrochloride, and chlorpheniramine maleate in tablet formu-
lations using an isocratic mixed micellar mobile phase (Biemer,
1987). In 1996, De Orsi et al. have developed an LC method for
the determination of paracetamol, pseudophedrine hydrochlo-
ride, dextromethorphan hydrobromide, and triprolidine in dif-
ferent pharmaceutical dosage forms using a reversed-phase C18
column and gradient elution and using two different wave-
lengths (De Orsi et al., 1996). In 2001, Patil et al. have devel-
oped and validated an HPLC method for simultaneous
determination of paracetamol, pseudophedrine hydrochloride,
dextromethorphan hydrobromide, and guaifenesin in bulk and
pharmaceutical dosage forms using the technique of packed
column supercritical ﬂuid chromatography and a hypersil phe-
nyl column with a ternary mobile phase (Patil et al., 2001).
Chen et al. have also described in 2001 an HPLC method for
the simultaneous determination of chlorpheniramine maleate,
paracetamol, and pseudophedrine hydrochloride in tablet for-OMe
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Figure 1 Structure of dextromethorphan, chlorphenamine,
pseudoephedrine, and paracetamol.mulations (Chen et al., 2001). In 2003, Milenkova et al. have
developed an HPLC method for simultaneous determination
of paracetamol, pseudophedrine hydrochloride, and dextro-
methorphan hydrobromide in tablet preparations (Milenkova
et al., 2003). In 2006, Murtha et al. have developed a method
for simultaneous determination of pseudophedrine hydrochlo-
ride, dextromethorphan hydrobromide, chlorpheniramine
maleate in tablet preparations by second-derivative photodiode
array spectroscopy (Murtha et al., 2006).
The aim of the current work is to develop a simple and
simultaneous HPLC method for the determination of pseud-
ophedrine hydrochloride, dextromethorphan hydrobromide,
chlorpheniramine maleate, and paracetamol without using
ion-pairing agent in the mobile phase. Validation of the cur-
rent method was conducted for these ingredients which include
accuracy, precision, selectivity, linearity and range, robustness
and ruggedness.
2. Experimental
2.1. Chemicals
Methanol HPLC grade is from J.T Baker (NJ, USA).Methanol
AR and ammonium dihydrogen phosphate are from Merck
(Darmstadt, Germany). Pseudophedrine hydrochloride, dex-
tromethorphan hydrobromide, chlorpheniramine maleate, and
paracetamol are from USP (Rockville, MD, USA).
2.2. Apparatus
LC system (Dionex System, USA) with a detector (PDA-3000,
08011275), equippedwith a pump (LPG-3400A, 8007455), auto-
sampler (WPS-300SL analytical 8008961), column compart-
ment (TCC-3000, 8008864), and solvent rack (SR-3000) was
employed during this study. The Chromeleon software was em-
ployed. The chromatographic analysis was performed on a
Nova-pak silica column (4 lm), (15.0 cm length, 3.9 mm inner
diameter) (WatersCorporation,Milford,Massachusetts,USA).
2.3. Standard solutions and HPLC conditions
Phosphate buffer was prepared by dissolving 1.15 g of ammo-
nium dihydrogen phosphate in 1000 ml of water. A ﬁltered and
degassed mixture of methanol and buffer (90:10, v/v) was em-
ployed as a mobile phase at a ﬂow rate of 1.0 ml/min and a
detection wavelength of 220 nm.
Stock standard solution was prepared by dissolving 500 mg
of paracetamol, 150 mg of dextromethorphan hydrobromide,
300 mg of pseudophedrine hydrochloride, and 20 mg of chlor-
pheniramine maleate in 100.0 ml of methanol. Nominal stan-
dard solution was prepared by diluting 5 ml of stock standard
solution to 50 ml with mobile phase to obtain a solution
having a known concentration of 0.50 mg/ml of paracetamol,
0.15 mg/ml of dextromethorphan hydrobromide, 0.30 mg/ml
of pseudophedrine hydrochloride, and 0.02 mg/ml of chlorphe-
niramine maleate.
Nominal solutions of the formulated tablets were prepared
by dissolving a quantity of the powdered tablet equivalent to
30.0 mg of pseudophedrine hydrochloride in 100.0 ml of
mobile phase to get the same concentration as in the standard
solution.
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3.1. Method development
Preliminary studies involved trying phenyl and silica columns
and testing several mobile phase compositions for the effective
separation of pseudophedrine hydrochloride, dextromethor-
phan hydrobromide, chlorpheniramine maleate, and paraceta-
mol. Silica column (4 lm, 15.0 cm length, 3.9 mm inner
diameter) eluted with a mobile phase of methanol/ammonium
dihydrogen phosphate buffer (90:10, v/v) at a ﬂow rate of
1.0 ml/min and a detection wavelength of 220 nm afforded
the best separation of these analytes, see Fig. 2 and Table 1.
3.2. Method validation
After method development, the validation of the current meth-
od has been performed in accordance with USP requirements
for assay determination (Category-I: analytical methods for
quantitation of active ingredients in ﬁnished pharmaceutical
products) which include accuracy, precision, selectivity, linear-
ity and range, robustness and ruggedness.
3.2.1. Linearity and range
To evaluate linearity of the method, different concentrations of
the four analytes in the range of 0.25–0.75 mg/ml for paraceta-
mol, 0.15–0.45 mg/ml for pseudophedrine hydrochloride,
0.075–0.225 mg/ml for dextromethorphan hydrobromide, and0 1 2 3 4 5 6 7 8 9
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Figure 2 Chromatogram of paracetamol (1), pseudophedrine
hydrochloride (2), dextromethorphan hydrobromide (3), and
chlorpheniramine maleate (4) in tablet formulation. Mobile phase:
methanol:ammonium dihydrogen phosphate buffer (90:10, v/v).
Flow rate: 1.0 ml/min, injection volume: 20 ll. Column: silica
(4 lm, 15.0 cm length, 3.9 mm inner diameter), UV detection:
220 nm.
Table 1 Chromatographic parameters of the separated analytes in
Analyte Capacity factor (k) Select
Paracetamol 1.8 /
Pseudophedrine hydrochloride 3.6 1.9
Dextromethorphan hydrobromide 5.4 1.50
Chlorpheniramine maleate 7.2 1.330.01–0.03 mg/ml for chlorpheniramine maleate were analyzed
and the linearity between the peak-area and the concentration
was examined for each analyte. The results obtained show
that the current method is linear for the three analytes in the
range speciﬁed above with a correlation coefﬁcient of better
than 0.99.
3.2.2. Accuracy (recovery)
Accuracy of the method was studied by preparing the placebo
of the drug tablet formulation according to the formulation
procedure. To the required quantity of placebo, a known
quantity of the four active ingredients (paracetamol, pseud-
ophedrine hydrochloride, dextromethorphan hydrobromide,
and chlorpheniramine maleate) with the same proportion as
in the drug formulation was added to get simulated drug for-
mulation. Results have shown that the mean recovery of the
assay is within 100 ± 2.0% for each ingredient, and the
RSD is lower than 1.0%, see Table 2.
3.2.3. Precision
The precision of this method was evaluated by calculating the
RSD of the peak areas of six replicate injections of the nominal
standard solution, which was found to be 0.57%, 0.30%,
0.82%, and 0.72% for pseudophedrine hydrochloride, dextro-
methorphan hydrobromide, chlorpheniramine maleate, and
paracetamol, respectively. Furthermore, the RSD of three rep-
licates of the recovery data analyzed in accuracy study was cal-
culated, and it was found to be less than 1.0%, see Table 2.
These results show that the current method is repeatable.
3.2.4. Selectivity
Selectivity of the current method was demonstrated by good
separation of the four analytes from each other, see Fig. 2.
Furthermore, excipient of the tablet formulation did not inter-
fere with the active ingredients of the drug product, see Fig. 2.
3.2.5. Robustness and ruggedness
Robustness of an analytical method is a measure of its capacity
to remain unaffected by small but deliberate variations in
method parameters, and provides an indication of its reliabilityFig. 2.
ivity (a) Resolution Asymmetry Theoretical plates
/ 1.32 2700
3.6 1.25 2700
4.2 1.40 2300
3.1 1.38 2100
Table 2 Accuracy (% recovery) of paracetamol, pseudophe-
drine hydrochloride, dextromethorphan hydrobromide, and
chlorpheniramine maleate in tablet formulation.
Analyte Accuracy
(% recovery)
RSD for three
replicates (%)
Paracetamol 99.2 0.63
Pseudophedrine hydrochloride 99.7 0.71
Dextromethorphan hydrobromide 98.6 0.82
Chlorpheniramine maleate 98.1 0.40
Table 3 Robustness testing of the current method.
Parameter Assay
Pseudophedrine hydrochloride Dextromethorphan hydrobromide Chlorpheniramine maleate Paracetamol
Flow rate (ml/min) 1.3 99.3 98.1 100.7 99.5
1.5 98.5 98.3 101.5 98.6
1.7 100.0 97.6 100.7 100.0
% Methanol 83 99.1 99.0 99.8 100.2
85 101.0 98.1 99.1 99.9
87 100.3 99.0 101.0 100.7
Wave length (nm) 215 100.0 98.5 98.8 98.9
220 99.8 98.6 99.2 99.3
225 99.8 99.3 99.9 99.7
Assay average 99.8 98.5 100.1 99.6
106 F. Al-Rimawiduring normal usage. Robustness of the current method was
investigated by analyzing samples of the drug product using
the same chromatographic conditions set forth in method
development but with a small change in the following chro-
matographic parameters: (a) ﬂow rate: 1.3 and 1.7 ml/min in-
stead of 1.5 ml/min, (b) detection wavelength: 215 and
225 nm instead of 220 nm, and (c) volume fraction of metha-
nol: 83% and 87% instead of 85%. RSD of pseudophedrine
hydrochloride, dextromethorphan hydrobromide, chlorphenir-
amine maleate, and paracetamol assay under these conditions
is calculated to be less than 1%, see Table 3.
Ruggedness of the current method was demonstrated by
analyzing six samples (assay) of tablet formulation by two ana-
lysts in the same laboratory. The RSD for the 12 samples is
calculated to be 0.55%, 0.62%, and 0.49% for pseudophedrine
hydrochloride, dextromethorphan hydrobromide, and chlor-
pheniramine maleate, respectively, indicating the ruggedness
of the method.
4. Conclusions
A simple, accurate, precise LC method is developed and vali-
dated for simultaneous determination of pseudophedrine
hydrochloride, dextromethorphan hydrobromide, chlorphenir-
amine maleate, and paracetamol in tablet formulation.Acknowledgments
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